搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
26 分钟
Eli Lilly Missed Sales Expectations Again. Should Investors Be Worried?
In the first half of 2024, it seemed Eli Lilly (NYSE: LLY) could do no wrong. Is Eli Lilly a good stock to buy on the dip? On ...
来自MSN
15 小时
Hims vs Ro: Which Weight Loss Program Fits You Best?
Losing weight can feel like climbing a mountain with no clear path. The one-size-fits-all advice—like “eat less, move ...
19 小时
Medicare to negotiate prices for weight loss drugs: What to know
The Biden administration says it will be including weight loss drugs like Ozempic and Wegovy in the next round of drug ...
22 小时
Eli Lilly Stock Tumbles on Slower-Than-Expected Weight Loss Drug Sales. Is This a Buying ...
GLP-1 drugs have become all the rage for weight loss, with sales for drugs like Novo Nordisk's Ozempic and Eli Lilly's (NYSE: ...
来自MSN
23 小时
The Science Behind Mitolyn: Dr. Andrew Lambert’s Purple Peel Exploit Explained
The quest for effective weight-loss solutions is a journey many embark on, often seeking products that promise to accelerate ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈